Year: 2012
Type: article
Abstract: Depression is associated both with a reduced size of brain regions regulating mood and cognition, including the pre-frontal cortex and the hippocampus, and decreased neuronal synapses in these areas. Antidepressants can block or reverse these neuronal deficits although they have lim-ited efficacy and delayed response time of weeks or months. Basic studies show that ketamine, an N-methyl-D-asparate (NMDA) receptor antagonist, produces rapid (within hours) antidepressant effects in patients with chronic depression who are resistant to typical antidepressants (Zarate et al., 2006; Machado-Vieira et al.,
Author: Bernhard J. Mitterauer
Institution: University of Salzburg
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W1982789189
